Not sure about October but in the Automic Invest conference...

Not sure about October but in the Automic Invest conference (December 23) Nan mentions that the B2C will be launched in Australia in the next couple of months - so any time now really. We are currently pending TGA approval of the active ingredient in the VesiSorb product, Avani Rapid. The Veterans brand RapMed is online and making sales. A great initiative to get into the market supporting Aussie Veterans and test the B2C waters whilst ironing out the creases before moving to larger scale B2C. The VesiSorb tech will be huge for ECS in that it makes the ingredient 4x more bioavailabe and 3x faster acting. I expect this will be a stand out to prescribing doctors as well as consumers. I'm really excited for both the organic certification and the eventual launch of Avani Rapid. Both pivotal moments in the journey IMO.